Pain drug in pipeline as researchers unwind marine snail puzzle

April 13, 2016, University of Queensland
Credit: David Wilson

A University of Queensland researcher has made a big step toward the holy grail of biomedical science—a new form of effective pain relief.

School of Biomedical Sciences researcher Dr Richard Clark said marine snail was a well-known and promising source of new pain drugs, but substantial hurdles had restrained progress.

"Translating the venom's toxins into a viable drug has proved difficult," Dr Clark said.

"But now we've been able to identify a core component of one of these conotoxins (toxins from cone snail venom) during laboratory tests.

"We think this will make it much easier to translate the active ingredient into a useful drug."

Dr Clark said a sea snail used its venom to immobilise prey and protect itself.

"The venom's analgesic have been well researched," he said.

"In this study, we've been able to shrink a particular conotoxin to its minimum necessary components for the pain relief properties to continue to work.

"Using a laboratory rat model, we used the modified conotoxin to successfully treat pain generated in the colon, similar to that experienced by humans with .

"Although the conotoxin has been modified, its properties remained as effective as the full-size model.

"Simplifying the conotoxin will make a drug much faster and cheaper to develop."

Dr Clark said further research was under way to improve the modified conotoxin's stability and to test its ability to treat other types of pain.

The research, published in Angewandte Chemie International Edition, was undertaken in collaboration with Professor David Craik at UQ's Institute for Molecular Bioscience, Professor David Adams at the Royal Melbourne Institute of Technology and Associate Professor Stuart Brierley at the University of Adelaide.

Explore further: Advance toward developing an oral pain reliever derived from debilitating snail venom

More information: Bodil B. Carstens et al. Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABA Receptor Activation Reveal a Minimal Functional Motif , Angewandte Chemie International Edition (2016). DOI: 10.1002/anie.201600297

Related Stories

Killer sea snail a target for new drugs

July 6, 2015

University of Queensland pain treatment researchers have discovered thousands of new peptide toxins hidden deep within the venom of just one type of Queensland cone snail.

How cone snail venom minimizes pain

May 14, 2014

The venom from marine cone snails, used to immobilize prey, contains numerous peptides called conotoxins, some of which can act as painkillers in mammals. A recent study in The Journal of General Physiology provides new insight ...

Recommended for you

A better HIV test

January 22, 2018

Public health officials have a tough choice to make when it comes to screening people for HIV: administer a reliable blood test that can detect infections early on, but that few people will volunteer for, or give people a ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

rrrander
not rated yet Apr 14, 2016
Another happy new invention! In five years, morphine-based pain-killers will still dominate, the companies that make oxycodone,etc., will still be raking in billions and dummies will still be abusing and overdosing on them.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.